No insider purchase over the last 90 days. The latest was filed 01 May 2026.
Every trade that managers of GE HealthCare Technologies Inc. disclose to SEC (Form 4) is tracked on this page. The company is based in Chicago, United States. It was founded in 2004. The last twelve months, up to 18 October 2026, brought 52 filings signed by 13 insiders.
Every open-market trade in the period is a purchase: 3 purchases worth €474k, from 3 insiders, and not a single sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €213k, the purchase published on 30 April 2026 by Arduini Peter J is the largest of the period (0.0008% of market cap). On the buying side, the filings list 1 finance chief, 1 senior executive and 1 chief executive among the declarants.
In the case of 3 purchases, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The most recent open-market purchase was published on 1 May 2026, 170 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction.
Across the 5,808 companies tracked on its exchange, the median is 19 filings; at 52 filings, this issuer sits above that mark. Over the whole record (from 2023), the tally stands at 5 purchases and 7 sales. For the fiscal year to 31 December 2025, the annual 10-K puts revenue at 20.63 bn USD and net income at 2.08 bn USD, and the dividend at 0.14 USD per share.
In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate GE HealthCare Technologies Inc. Buy (bullish), based on 20 analysts. Average price target: US$82.70.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 212 declarations
GE HealthCare Technologies Inc. is a company focused on healthcare technologies, providing innovative solutions for diagnosis and treatment. It operates on the XNAS market.
Purchases our model currently ranks for the recommendations list.
All recommendationsHeadquarters: Chicago, United States · Founded: 2004 · Wikipedia article
Source: Wikidata (CC0).
| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Dec 2025 | 20.63 bn USD | 2.08 bn USD | 4.55 USD | 0.14 USD | 10-K |
| Dec 2024 | 19.67 bn USD | 1.99 bn USD | 4.34 USD | 0.13 USD | 10-K |
| Dec 2023 | 19.55 bn USD | 1.57 bn USD | 3.03 USD | 0.12 USD | 10-K |
| Dec 2022 | 18.34 bn USD | 1.92 bn USD | 4.22 USD | n.d. | 10-K |
| Dec 2021 | 17.59 bn USD | 2.25 bn USD | 4.95 USD | n.d. | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.